THE BUZZ
The group has announced a private placement of 300m new Maybank shares to shareholders representing 3.68% of the group's current issued share capital base. The pricing of the placement shares will only be determined on completion of a book building exercise which commenced last Friday. The group also stated that depending on demand, it may increase the quantum of new shares to be placed out. Accordingly, the group also proposed to raise its issued and paid up capital by up to 412m new Maybank shares. The proposed private placement is expected to complete by end-October 2012.
OUR TAKE
Ahead of the curve. We are a little surprised by the group's proposed private placement as the high reinvestment rate (averaging 85%) arising from its current dividend reinvestment plan should sufficiently enable it to scale up its Tier 1 core equity
capital ratios to levels above 11% by 2017. This should be more than adequate to enable it to meet even the most punitive core equity capital buffer ratios of 9.5%, assuming that Bank Negara Malaysia (BNM) imposed the maximum 2.5% counter cyclical buffer exceeding Basel 3's 7.0% minimum requirement. As such, we view the proposal as a move to beef up its core Tier 1 equity capital ratios ahead of the implementation of BNM's counter cyclical buffers from 2014.
Keeping high dividend payout while scaling back DRP. Assuming that the group issues 300m new shares and an indicative issue price of RM8.80 per share (a 3% discount on the 5-day weighted average share price of Maybank), the proposed capital raising exercise will raise RM2.64bn in new capital, which will consequently raise Maybank Group's Core Tier 1 Equity Ratio from 9.3% to 10.3%. Although its ROE will compress from 15.8% to 14.7%, the increase in book value will partially mitigate the effect of the lower ROE on our fair value, which will only come down by 2.8%. More importantly, the proposed private placement will allow the group to scale back its existing dividend reinvestment plan while maintaining a relatively high dividend payout ratio of above 60%. This step will remove the persistent overhang on ROE growth arising from the existing dividend reinvestment plan.
Vital in sustaining sizzling organic growth. Given the group's ambition to sustain its already robust Risk Weighted Asset growth rates of 17% p.a (annualised 1HFY12 RWA growth rates), coupled with Basel 3's stringent capital requirements and deductions (investment in subsidiaries and associates plus goodwill), we believe that the proposed capital raising exercise is aimed at placing the group ahead of the curve in meeting those demands while sustaining its currently robust organic growth. Consequently, we are positive on the exercise as: i) the quantum is relatively manageable and would make only a marginal impact on EPS dilution, ii) places the group well ahead of the curve in achieving strong capital buffers before BNM's counter cyclical buffers come into force from 2014 onwards, and iii) allows it to sustain growth rates above its peers, which will in turn consistently drive earnings upside surprises and ROE-re-rating.
Future sizeable acquisitions to require more capital. Depending on the scale of its future acquisitions, we believe that such potential purchases will coincide with additional capital-raising. As such, the group's latest proposed private placement is for the stated purpose of working capital requirements and general banking purposes. Assuming that the banking group goes ahead to bid for General Electric's (GE) 25% stake in Bank of Ayhudya (BAY) and pricing in a 20% premium from the current market value, we estimate that Maybank group may have to raise RM4bn more in new equity capital to sustain its Core Equity Tier 1 capital above 10.5%, and assuming full deduction of investment in associates as the acquisition of GE's stake in BAY may cost it RM6.4bn while giving rise to a goodwill of RM3.3bn. As such, we believe that pricing will be a key determinant in Maybank's potential acquisition of GE's 25% interest in BAY as the group has clearly stated that the acquisition should be EPS neutral from day.
Maintain BUY. We are maintaining our BUY recommendation and FV of RM10.30 (2.14x FY12 PBV, 15.8% ROE, 9.5% COE and 4% growth rates) for Maybank given its inexpensive 1.8x FY12PBV (cheapest among the top 3 banks) valuation, with ROEs on track to hit 16%. We are positive on the proposed private placement exercise since: i) the quantum is relatively manageable and would only be marginally EPS dilutive, ii) places the group way ahead of the curve in achieving strong capital buffers before BNM implements counter cyclical buffers from 2014 onwards, and iii) allows the group to sustain growth rates above its peers, thereby consistently driving earnings upside surprises and ROE-re-rating.